glutathione pathway to triple negative cancer

glutathione pathway to triple negative cancer Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Activation of the eIF2α/ATF4 axis

Name: glutathione pathway to triple negative cancer Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Activation of the eIF2α/ATF4 axis
Brand: southroadsurgery.com.au
SKU: 17828996596
Price: 23.29 USD
Availability: InStock
Rating: 4.4284 (18 reviews)

Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect Frontiers Oxidative stress and antioxidants in breast cancer: a double edged sword Apoptosis and glutathione: beyond an antioxidant Cell Death & Differentiation Role of Glutathione in Cancer: From Mechanisms to Therapies Salidroside sensitizes Triple negative breast cancer to ferroptosis by SCD1 mediated lipogenesis and NCOA4 mediated ferritinophagy ScienceDirect Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy

SKU: 17828996596 · From southroadsurgery.com.au

4.4

USD23.29 USD53.29

Pay in 4 interest-free payments of $5.82 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

M.MartnezJ

Minimize dust formation

Low brain allopregnanolone levels mediate flattened circadian activity associated with memory impairments in aged rats

J Biol Chem 282:3059630606 Joseph JW, Jensen MV, Ilkayeva O et al (2006) The mitochondrial citrate/isocitrate carrier plays a regulatory role in glucose-stimulated insulin secretion